TRCT
EVAR

Tower Research Capital (TRC)’s Lombard Medical, Inc. EVAR Stock Holding History

Tower Research Capital (TRC)’s Portfolio EVAR Stock Details EVAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,345
Closed -$5K – 5481
2015
Q3 		$5K Buy
+1,345
New +$5.15K ﹤0.01% 2869
2015
Q2 		– Sell
-613
Closed -$2K – 5418
2015
Q1 		$2K Buy
613
+171
+39% +$880 ﹤0.01% 3913
2014
Q4 		$3K Buy
442
+62
+16% +$407 ﹤0.01% 3221
2014
Q3 		$3K Sell
380
-1,779
-82% -$11.8K ﹤0.01% 3688
2014
Q2 		$16K Buy
+2,159
New +$17.6K ﹤0.01% 2014

Other funds holding EVAR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Tower Research Capital (TRC)'s EVAR Position: Q4 2015 in Review

Tower Research Capital (TRC) sold out of Lombard Medical, Inc. (EVAR) in Q4 2015, closing a stake of 1,345 shares — an estimated $5K sold.

Tower Research Capital (TRC) first reported a position in EVAR in Q2 2014 and held it in 5 quarters. The position peaked at $16K in Q2 2014. 18 funds tracked by Wall St. Rank hold EVAR as of Q4 2015.

  • Tower Research Capital (TRC) reported no remaining Lombard Medical, Inc. position as of Q4 2015 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,345 Lombard Medical, Inc. shares in Q4 2015, an estimated $5K.
  • Tower Research Capital (TRC) first reported a position in Lombard Medical, Inc. in Q2 2014 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s Lombard Medical, Inc. position peaked at $16K in Q2 2014.
  • 18 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2015, filed 10 Feb 2016.